UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Cash Flows From Operating Activities:
Net earnings	$ 36,930	$ 27,051
Adjustments to reconcile net earnings to net cash (used in) provided by operating activities:
Depreciation and amortization	11,441	11,801
Provision for credit losses, inventory obsolescence and sales returns	275	250
Share-based compensation expense	3,428	2,965
Excess tax benefit from share-based compensation	(734)	(1,366)
Deferred taxes	(59)	(278)
Payments from lessees directly to lenders-operating leases	(6,011)	(5,857)
Gain on disposal of property, equipment and operating lease equipment	(2,438)	(1,550)
Gain on sale of financing receivables	(4,640)	(5,707)
Gain on settlement	(1,434)	0
Other	105	70
Changes in:
Accounts receivable - trade	(27,378)	(39,585)
Accounts receivable - other	4,492	(3,599)
Inventories	(314)	(9,182)
Financing receivables	(14,927)	(20,124)
Deferred costs, other intangible assets and other assets	(6,309)	(410)
Accounts payable-equipment	(578)	2,453
Accounts payable-trade	(15,451)	10,816
Salaries and commissions payable, deferred revenue and other liabilities	13,672	5,486
Net cash used in operating activities	(9,930)	(26,766)
Cash Flows From Investing Activities:
Maturities of short-term investments	0	982
Maturities of supplemental benefit plan investments	2,544	0
Proceeds from sale of property, equipment and operating lease equipment	7,401	3,280
Purchases of property, equipment and operating lease equipment	(7,571)	(7,938)
Purchases of assets to be leased or financed	(7,628)	(8,278)
Issuance of financing receivables	(93,205)	(68,033)
Repayments of financing receivables	50,577	33,497
Proceeds from sale of financing receivables	24,216	28,270
Premiums paid on life insurance	(47)	(163)
Cash used in acquisitions, net of cash acquired	(7,992)	(2,845)
Net cash used in investing activities	(31,705)	(21,228)
Cash Flows From Financing Activities:
Borrowings of non-recourse and recourse notes payable	40,329	29,020
Repayments of non-recourse and recourse notes payable	(1,580)	(2,247)
Repurchase of common stock	(37,080)	(10,308)
Dividends paid	(90)	(107)
Proceeds from issuance of capital stock through option exercise	0	559
Payments of contingent consideration	0	(1,027)
Excess tax benefit from share based compensation	734	1,366
Net borrowings (repayments) on floor plan facility	10,689	18,510
Net cash provided by financing activities	13,002	35,766
Effect of exchange rate changes on cash	(24)	6
Net Decrease in Cash and Cash Equivalents	(28,657)	(12,222)
Cash and Cash Equivalents, Beginning of Period	80,179	52,720
Cash and Cash Equivalents, End of Period	51,522	40,498
Supplemental Disclosures of Cash Flow Information:
Cash paid for interest	201	100
Cash paid for income taxes	26,233	16,769
Schedule of Non-Cash Investing and Financing Activities:
Purchase of property and equipment included in accounts payable	243	75
Purchase of operating lease equipment included in accounts payable	93	308
Purchase of assets to be leased or financed included in accounts payable	15,633	3,997
Proceeds from sales of operating lease equipment included in accounts receivable	297	10
Repayments of non-recourse and recourse notes payable	26,469	15,147
Vesting of share-based compensation	6,439	7,804
Origination and concurrent sale of financing receivables	79,663	102,131
Contingent consideration	$ 1,980	$ 0